Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00246454 · ClinicalTrials.gov registry record

Circadian Rhythms and Sleep in Familial DSPS and ASPS

A clinical trial, sponsored by Northwestern University.

Completed
Registry status
156
Enrollment target

NCT00246454: Completed study, sponsored by Northwestern University.

NCT00246454 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 156 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00246454 has completed, sponsored by Northwestern University.

COMPLETED
Registry status
156 participants
Enrollment target

Study Summary

The purpose of this study is to determine the properties of circadian rhythms and sleep propensity in familial advanced and delayed sleep phase syndrome (DSPS).

Primary Outcome

Assessment of sleep parameters

Trial Details

FieldValue
Enrollment Target 156 participants
Start Date 2003-09
Est. Completion 2024-03-27
Northwestern University

1,209 total trials

What the finished NCT00246454 record still lists

NCT00246454 is an observational study that tracks outcomes without assigning an intervention. The registered 156 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00246454 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00246454 about?

NCT00246454 is a clinical study titled "Circadian Rhythms and Sleep in Familial DSPS and ASPS". The purpose of this study is to determine the properties of circadian rhythms and sleep propensity in familial advanced and delayed sleep phase syndrome (DSPS).

What is the current status of trial NCT00246454?

This trial is currently completed. The enrollment target is 156 participants. The study started on 2003-09. Estimated completion is 2024-03-27.

Who is sponsoring clinical trial NCT00246454?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03082755 · 156 participants · Phase 4

    Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease

  • NCT04047628 · 156 participants · Phase 3

    Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

  • NCT04166877 · 156 participants · Phase 4

    Magnesium Infusion for Pain Management in Critically Ill Trauma Patients

  • NCT04533464 · 156 participants · Phase 2

    MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00246454, the US trial registry maintained by the National Library of Medicine. NCT00246454 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.